Stake Announced
Eli Lilly and Company stake in InduPro Therapeutics
Announced 12 Jan 2026
Advisers
InduPro Therapeutics
Target
Not disclosed
Eli Lilly and Company
Acquirer
- Legal adviser
- Target
- InduPro Therapeutics
- Acquirer
- Eli Lilly and Company
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Structure
- Minority stake
- Sector
- Biotech
- Tags
- Biotech, Oncology, AI
In the league tables
Similar deals
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Novartis acquisition of Myricx Bio Jul 2026 · US$1.1bn · Biotech
- Ipsen acquisition of Kartos Therapeutics Jun 2026 · US$450m · Biotech
- Passage Bio and Remix Therapeutics merger Jun 2026 · Biotech
- GSK acquisition of Nuvalent Jun 2026 · US$11bn · Biotech